Scientists at Memorial Sloan Kettering Cancer Center (MSK) and their colleagues are shedding new light on a tumor's earliest ...
As the body ages, cells naturally accumulate dozens of genetic mutations each year. New research from Boston Children's Hospital, published in Cell, finds that the brain's resident immune cells, ...
Daraxonrasib, a pancreatic cancer drug from Revolution Medicines, is showing unprecedented success. For patients like Leanna ...
New clinical trial data show KRAS-blocking drugs may significantly improve survival for the disease. “I think this is truly ...
Michele Carbone and Haining Yang, professors at University of Hawaiʻi Cancer Center, are recipients of the prestigious V ...
Breast cancer is one of the most common malignancies worldwide, and mutations in the PI3K/AKT/mTOR (PAM) signaling pathway ...
A newly proposed model suggests cancer cells may resist treatment not just through genetic mutations, but by dynamically reprogramming their gene activity. Credit: Shutterstock Cancer cells may “learn ...
EO1001 demonstrates up to ~40-fold greater potency than osimertinib in EGFR ECD-mutant tumor models EO4426 (tezacitabine) demonstrates selective targeting of DNA replication machinery and resistance ...
New research from Boston Children’s Hospital, published in Cell, finds that the brain’s resident immune cells, microglia, ...
Triple-negative breast cancer (TNBC), particularly the luminal androgen receptor (LAR) subtype, presents significant ...
A large-scale genomic study published February 19 in Science has produced the first comprehensive map of the feline ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results